Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Jade Biosciences, Inc. (JBIO) had Free Cash Flow per Share of $-87.40 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-69.63M |
|
-- |
|
-- |
|
$74.60M |
|
$-74.60M |
|
$5.02M |
|
$-69.57M |
|
$-69.57M |
|
$-69.63M |
|
$-69.63M |
|
$-69.63M |
|
$-69.63M |
|
$-74.60M |
|
$-76.56M |
|
0.81M |
|
0.81M |
|
$-85.61 |
|
$-85.61 |
|
| Balance Sheet Financials | |
$80.12M |
|
$0.01M |
|
$0.21M |
|
$80.33M |
|
$3.83M |
|
-- |
|
$0.07M |
|
$3.90M |
|
$76.43M |
|
$76.43M |
|
$76.43M |
|
0.83M |
|
| Cash Flow Statement Financials | |
$-71.20M |
|
$56.03M |
|
$25.43M |
|
$23.49M |
|
$33.75M |
|
$10.26M |
|
$11.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-71.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-91.10% |
|
-91.10% |
|
-86.68% |
|
-91.10% |
|
$92.53 |
|
|
Free Cash Flow per Share |
$-87.40 |
$-87.40 |
|